BAKER BROS. ADVISORS LP – Inozyme Pharma, Inc. Transaction History
BAKER BROS. ADVISORS LP portfolio value:
$0
portfolio value
BAKER BROS. ADVISORS LP quarter portfolio value change:
-43.82%
quarter
Inozyme Pharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -100.00% | -106.99K shares | -510K | $2.68 | 0 |
| Q2 2022 | share | 0.00% | 0 shares | 72K | $4.77 | 106.99K | |
| Q1 2022 | share | 0.00% | 0 shares | -292K | $4.09 | 106.99K | |
| Q4 2021 | share | 0.00% | 0 shares | -510K | $6.95 | 106.99K | |
| Q3 2021 | share | 0.00% | 0 shares | -583K | $11.59 | 106.99K | |
| Q2 2021 | share | 0.00% | 0 shares | -296K | $17.04 | 106.99K | |
| Q1 2021 | share | 0.00% | 0 shares | -89K | $19.8 | 106.99K | |
| Q4 2020 | share | Decrease | -9.71% | -11.50K shares | -907K | $20.64 | 106.99K |
| Q3 2020 | share | Increase | 0.00% | 118.5K shares | 3.11M | $26.29 | 118.5K |